...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >A comparative study of anticonvulsant effect of phenytoin and lamotrigine in albino mice
【24h】

A comparative study of anticonvulsant effect of phenytoin and lamotrigine in albino mice

机译:苯妥英钠和拉莫三嗪对白化病小鼠抗惊厥作用的比较研究

获取原文
           

摘要

Background: The anticonvulsant activity of lamotrigine has been extensively studied and its role is established. Lamotrigine have shown recently to be useful in various epileptic seizures. Since antiepileptic drugs are used for longer duration, so less toxic drugs should be chosen. So, in the present study the Lamotrigine has been chosen to compare the anticonvulsant action, effectiveness, toxicity and lethal dose of the drug used in the study keeping the phenytoin as a standard drug. Methods: The present study has been carried out in the Department of Pharmacology, Darbhanga Medical College, Laheriasarai. Induction of seizure with the help of electro-convulsiometer in albino mice was done followed by the observation of the anti-convulsant activity of lamotrigine in comparison with phenytoin sodium was made. Side effects or toxicity of the drugs used (Acute neurotoxicity) was observed. Results: Lamotrigine caused lower mortality in comparison to phenytoin for the same dose ranges. The anticonvulsant properties of Lamotrigine were compared with phenytoin and the effect has been found to be satisfactory. Lamotrigine protected experimentally induced grand mal seizure and was observed to be ineffective against experimentally induced petit mal seizure. The ED 50 of Lamotrigine was found to be higher and the toxic dose was also higher in comparision with standard drugs. The protective index of lamotrigine was found to be less than that of phenytoin. Margin of safety of the drug was found to be more due to their shorter protective index than that of phenytoin. Conclusions: Lamotrigine can be used clinically as anticonvulsant in Grandmal type of epilepsy but not in Petitmal epilepsy, and has equivocal anticonvulsant effect but slightly less toxicity to phenytoin but further elaborate screening of the drug by various experiments is needed to come to a precise conclusion.
机译:背景:拉莫三嗪的抗惊厥活性已得到广泛研究,其作用已经确立。拉莫三嗪最近已显示可用于各种癫痫发作。由于抗癫痫药物的使用时间较长,因此应选择毒性较小的药物。因此,在本研究中,选择拉莫三嗪来比较该研究中使用的苯妥英钠作为标准药物的抗惊厥作用,有效性,毒性和致死剂量。方法:本研究已在Laheriasarai的Darbhanga医学院药理学系进行。借助电惊厥仪诱导白化病小鼠癫痫发作,然后观察拉莫三嗪与苯妥英钠的抗惊厥活性。观察到所用药物的副作用或毒性(急性神经毒性)。结果:在相同剂量范围内,拉莫三嗪与苯妥英钠相比,死亡率更低。将拉莫三嗪的抗惊厥特性与苯妥英进行了比较,发现效果令人满意。拉莫三嗪可保护实验性癫痫大发作,并观察到对实验性小癫痫发作无效。与标准药物相比,发现拉莫三嗪的ED 50更高,毒性剂量也更高。发现拉莫三嗪的保护指数小于苯妥英。由于其保护指数短于苯妥英钠,因此发现该药物的安全性裕度更大。结论:拉莫三嗪可在临床上用作Grandmal型癫痫的抗惊厥药,但不能用于Petitmal癫痫,具有明确的抗惊厥作用,但对苯妥英钠的毒性较小,但需要通过各种实验进一步详细筛选该药物,才能得出准确的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号